- Home
- BNTC vs AIP Comparison
BNTC vs AIP Comparison
Compare BNTC & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- AIP
- Stock Information
- Founded
- BNTC 1995
- AIP 2003
- Country
- BNTC United States
- AIP United States
- Employees
- BNTC N/A
- AIP N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- BNTC Health Care
- AIP Technology
- Exchange
- BNTC Nasdaq
- AIP Nasdaq
- Market Cap
- BNTC 366.6M
- AIP 336.2M
- IPO Year
- BNTC N/A
- AIP 2021
- Fundamental
- Price
- BNTC $12.89
- AIP $9.08
- Analyst Decision
- BNTC Strong Buy
- AIP Strong Buy
- Analyst Count
- BNTC 6
- AIP 3
- Target Price
- BNTC $23.83
- AIP $15.00
- AVG Volume (30 Days)
- BNTC 234.8K
- AIP 660.1K
- Earning Date
- BNTC 05-14-2025
- AIP 07-31-2025
- Dividend Yield
- BNTC N/A
- AIP N/A
- EPS Growth
- BNTC N/A
- AIP N/A
- EPS
- BNTC N/A
- AIP N/A
- Revenue
- BNTC N/A
- AIP $61,309,000.00
- Revenue This Year
- BNTC N/A
- AIP $19.82
- Revenue Next Year
- BNTC N/A
- AIP $17.29
- P/E Ratio
- BNTC N/A
- AIP N/A
- Revenue Growth
- BNTC N/A
- AIP 14.68
- 52 Week Low
- BNTC $7.05
- AIP $5.46
- 52 Week High
- BNTC $17.15
- AIP $12.64
- Technical
- Relative Strength Index (RSI)
- BNTC 50.13
- AIP 59.29
- Support Level
- BNTC $12.57
- AIP $9.00
- Resistance Level
- BNTC $13.88
- AIP $9.76
- Average True Range (ATR)
- BNTC 1.18
- AIP 0.60
- MACD
- BNTC 0.02
- AIP -0.02
- Stochastic Oscillator
- BNTC 62.63
- AIP 60.68
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.